When Rianta Wimberly started going blind from an inoperable brain tumor, her mother Glenda got on the Web, found a radiation treatment called proton beam therapy and sent a desperate email to doctors at Massachusetts General Hospital, CBS News’ Dr. Emily Senay reports.
Monthly Archive for March, 2008
Marian Dolishny’s nervous smile and worried, flicking eyes, betray the certain knowledge that what he is about to undergo will be anything but pleasant. But he also knows that time is short: if the enormous tumour inside his head is not removed, it will soon kill him.
Melanie was 9 months old when her parents faced an agonizing decision. She had already had two operations for a malignant brain tumor, and doctors could not be sure they had removed all the cancer. She needed more treatment, but standard chemotherapy offered little hope in exchange for its harsh side effects. And yet the McDaniels knew that if they did nothing, the odds were high that the tumor would come back.
Brain surgeon with big heart gives free ops to cops
Posted in News on Mar 17th, 2008
Dr. Patrick Kelly, a professor of neurosurgery at NYU Medical Center, operates on police officers free of charge.
After an MRI, she learns she has a brain tumor. It’s small and benign, but it takes over her life. Any small headache can send her spiraling out of control with fear and running for her mom’s bed.
Genentech to Apply for New Cancer Indication for Avastin
Posted in News on Mar 15th, 2008
Genentech announced it will submit a supplemental Biologics License Application (sBLA) this year for accelerated FDA approval to use its oncology drug Avastin to treat relapsed glioblastoma multiforme (GBM).
The boy and his doctors are waging a battle against a deadly glioma tumor lodged at the base of Brian’s brain stem. The disease affects the central nervous system.
A discovery by St. Jude Children’s Research Hospital scientists suggests a safer way to treat medulloblastoma, a rare but often fatal childhood brain tumor.
Girl who inspired ‘Steffanie’s Law’ dies
Posted in Legislation, News on Mar 13th, 2008
Steffanie Collings, namesake of legislation to require insurance coverage for routine health care costs for patients who undergo clinical trials, died today, a day after the bill passed the state Senate.
Cotara® Appears Safe and Well Tolerated in Dosimetry and Phase II Trials, with Some Patients Already Past the Expected Median Average Survival Time for This Population – - Data From Dosimetry Trial Accepted for Presentation at 2008 ASCO Annual Meeting
-
-
Recent Posts
- Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Research
- Free Brain Tumor Conference Spotlights Treatment, Support
- Cottonseed-Based Drug Shows Promise Treating Severe Brain Cancer, Say UAB Researchers
- Jackson grad endures loss of home, brain tumor
- The Taking Tree: Late Effects Are Teh Awesome
Archives
Categories
-